Recombinant Human CD161 Fc Chimera Protein, CF

R&D Systems | Catalog # 7448-CD

R&D Systems
100% Guarantee

Key Product Details

  • R&D Systems CHO-derived Recombinant Human CD161 Fc Chimera Protein (7448-CD)
  • Quality control testing to verify active proteins with lot specific assays by in-house scientists
  • All R&D Systems proteins are covered with a 100% guarantee

Source

CHO

Accession Number

Q12918

Applications

Bioactivity
View all CD161 Proteins and Enzymes »

Product Specifications

Source

Chinese Hamster Ovary cell line, CHO-derived human CD161 protein
Met-Asp Human IgG1
(Pro100-Lys330)		 IEGR Human CD161
(Lys68-Ser225)
Accession # Q12918
N-terminus C-terminus

Purity

>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.

Endotoxin Level

<0.01 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Met-Asp

Predicted Molecular Mass

45 kDa

SDS-PAGE

58-70 kDa, reducing conditions

Activity

Measured by its binding ability in a functional ELISA.
When Recombinant Human CD161 Fc Chimera is coated at 5 μg/mL (100 μL/well), the concentration of recombinant human CLEC-2A Fc Chimera that produces 50% optimal binding response is found to be approximately 2-10 μg/mL.

Formulation, Preparation, and Storage

7448-CD
Formulation Lyophilized from a 0.2 μm filtered solution in PBS.
Reconstitution

Reconstitute at 100 μg/mL in PBS.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.

Calculators

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Background: CD161

CD161 (also NKR-P1A, CLEC5B and KLRB1) is a 40-44 kDa member of the NKR (Natural Killer cell receptor) family, C-type lectin superfamily of molecules (1-4). It is a cell surface protein that is known to be expressed by distinct sets of lymphocytes. These include DN immature thymocytes (4), NK17 (CCR4+; Np44+; IL-23 R-) cells that secrete IL-17 (5), TCR alpha beta CD8 alpha + intestinal T cells (6), TCR alpha beta NKT cells (7), TCR gamma delta T cells (8), Type-2 Innate (CD127+ CRTH2+) lymphoid cells that produce IL-5 and IL-13 (9), immature CD56- CD16- NK cells (10), CD56+ CD16+ and CD56+ CD16- NK cells (3, 11, 12), and CD4+ Th17 plus CD8+ Tc17 IL-17 secreting T cells (13, 14). Although monocytes and dendritic cells have also been reported to express CD161, cells with antigen-presenting function are more often associated with expression of LLT1, the ligand for CD161 (15, 16). Human CD161 is a 225 amino acid (aa) type II transmembrane glycoprotein. It contains a 45 aa N-terminal cytoplasmic region, a 21 aa transmembrane segment, and a 159 aa extracellular domain (ECD) (aa 67-225) (3, 17). The ECD contains one C-type lectin domain (aa 101‑211) and, based on the mouse ortholog for human CD161, will utilize Cys74 for the creation of a disulfide-linked homodimer (3, 4). Full-length human CD161 shares 47% aa sequence identity with full-length mouse NK1.1/Ly55c, the closest mouse ortholog to human CD161. Within the ECD of these molecules, human CD161 shares 45% aa sequence identity with mouse NK1.1. The function of CD161 is not well understood. It is known to possess a weak ITIM motif (AIYAEL) in its cytoplasmic tail, and to utilize acid sphingomyelinase for signal transduction that results in the activation of PI3 kinase (18, 19). Unlike all the mouse orthologs for CD161, human CD161 does not possess a p56lck motif; the significance of this, however, is unclear (19). CD161 is generally regarded as a marker for IL-17 secreting cells (8, 16, 20). Whether its expression is a requisite for IL-17 secretion is uncertain. What does appear certain is the fact that CD161 activity is a function of the expressing cell type. Although the data is somewhat conflicting, on T cells, CD161 reportedly acts as an activation/potentiation receptor, increasing IFN-gamma production in concert with TCR engagement (16, 18, 21). On NK cells, CD161 ligation decreases cell-mediated cytotoxicity and IFN-gamma production (11, 16, 21, 22, 23). And on thymocytes, CD161 activation induces proliferation and down‑regulates innate cytolytic activity (4). Finally, CD161 may also function through binding to LLT1/CLEC2D (note: PILAR/CLEC2A was also previously reported to bind to CD161, but this is now in dispute) (22-25). When LLT1 is expressed on NK cells, its engagement by CD161 actually induces IFN-gamma production by NK cells, in contrast to the down‑regulation effect seen with CD161 ligation.

References

  1. Mesci, A. et al. (2006) Immunol. Res. 35:13.
  2. Carlyle, J.R. et al. (2008) Semin. Immunol. 20:321.
  3. Lanier, L.L. et al. (1994) J. Immunol. 153:2417.
  4. Poggi, A. et al. (1996) Eur. J. Immunol. 26:1266.
  5. Pandya, A.D. et al. (2011) PLos ONE 6:e26780.
  6. Turtle, C.J. et al. (2011) Blood 118:2752.
  7. Balato, A. et al. (2009) J. Invest. Dermatol. 129:1628.
  8. Maggi, L. et al. (2010) Eur. J. Immunol. 40:2174.
  9. Mjosberg, J.M. et al. (2011) Nat. Immunol. 12:1055.
  10. Bennett, I.M. et al. (1996) J. Exp. Med. 184:1845.
  11. Poggi, A. et al. (1998) Eur. J. Immunol. 28:1611.
  12. Azzoni, L. et al. (1998) J. Immunol. 161:3493.
  13. Annunziato, F. et al. (2008) Int, Immunol. 11:1361.
  14. Billerbeck, E. et al. (2010) Proc. Natl. Acad. Sci. USA 107:3006.
  15. Poggi, A. et al. (1997) Eur. J. Immunol. 27:2965.
  16. Germain, C. et al. (2011) J. Biol. Chem. 286:37964.
  17. SwissProt Accession # Q12918.
  18. Rosen, D.B. et al. (2008) 180:6508.
  19. Pozo, D. et al. (2006) J. Immunol. 176:2397.
  20. Cosmi, L. et al. (2008) J. Exp. Med. 205:1903.
  21. Kamishikiryo, J. et al. (2011) J. Biol. Chem. 286:23823.
  22. Aldemir, H. et al. (2005) J. Immunol. 176:7791.
  23. Rosen, D.B. et al. (2005) J. Immunol. 176:7796.
  24. Huarte, E. et al. (2008) Blood 112:1259.
  25. Germain, C. et al. (2010) J. Biol. Chem. 285:36207.
  26. Bambard, N.D. et al. (2010) Scand. J. Immunol. 71:210.

Alternate Names

CD161, CLEC5B, KLRB1, Ly59, NKR, NKRP1, NKRP1A

Entrez Gene IDs

3820 (Human); 25192 (Rat)

Gene Symbol

KLRB1

UniProt

Q12918

Additional CD161 Products

Product Documents for Recombinant Human CD161 Fc Chimera Protein, CF

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot or batch number in the search box below.

Note: Certificate of Analysis not available for kit components.

Download SDS

Product Specific Notices for Recombinant Human CD161 Fc Chimera Protein, CF

For research use only

Citations for Recombinant Human CD161 Fc Chimera Protein, CF

Customer Reviews for Recombinant Human CD161 Fc Chimera Protein, CF

There are currently no reviews for this product. Be the first to review Recombinant Human CD161 Fc Chimera Protein, CF and earn rewards!

Have you used Recombinant Human CD161 Fc Chimera Protein, CF?

Submit a review and receive an Amazon gift card!

$25/€18/£15/$25CAN/¥2500 Yen for a review with an image

$10/€7/£6/$10CAN/¥1110 Yen for a review without an image

Submit a review
Amazon Gift Card

FAQs

No product specific FAQs exist for this product.

View all FAQs for Proteins and Enzymes